Lipids & metabolic liver disease

Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in non-alcoholic fatty liver disease (NAFLD) patients: National Health and Nutrition Examination Survey (NHANES) 1999–2018

Cardiovasc DiabetolPublished Cross-sectional study with mortality follow-up

Authors' conclusion

In patients with NAFLD, CMI is a stronger predictor of non-fatal CVD than AIP. While both indices show limited value for predicting mortality, CMI holds promise as a practical supplementary tool for clinical risk assessment.

Study context

Population
Adults (≥18 years) with NAFLD, US NHANES 1999–2018
Participants
5,792 adults
Exposure
Highest vs lowest quartiles of atherogenic index of plasma (AIP) and cardiometabolic index (CMI)
Outcome
All-cause mortality, CVD mortality and CVD risk
Methodological detailsNHANES cohort analysis, weighted logistic regression, Cox proportional hazards models, restricted cubic spline, subgroup and mediation analyses, sensitivity analyses
  • NHANES cohort analysis
  • Weighted logistic regression
  • Cox proportional hazards models
  • Restricted cubic spline
  • Subgroup and mediation analyses
  • Sensitivity analyses

Main finding

As reported in the abstract

CHF (highest vs reference quartiles)
Highest quartile; adjusted
Odds ratio (95% CI)P value
AIP
3.157(1.684–5.922)
P < 0.001
CMI
3.604(1.843–7.047)
P < 0.001

Observational data: associations, not effects.

Further findings

Non-linear associations (restricted cubic spline (RCS))

Non-linear relationship between CMI and CHD, angina pectoris

All-cause mortality, age 40-60 subgroup

Both AIP and CMI showed high predictive value for all-cause mortality in the 40-60 age cohort

Mediation

Mets, NLR, hypertension and HOMA-IR partially mediated the associations

Incremental predictive value

Inclusion of AIP and CMI partially improved predictive capability of the basic model

Original publication

Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999–2018. Cardiovasc Diabetol. Published 3 February 2026. doi:10.1186/s12933-025-03043-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.